GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) » Definitions » PEG Ratio

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) PEG Ratio : N/A (As of May. 26, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Pharmedic Pharmaceutical Medicinal Joint Stock Company's PE Ratio without NRI is . Pharmedic Pharmaceutical Medicinal Joint Stock Company's 5-Year EBITDA growth rate is 0.00%. Therefore, Pharmedic Pharmaceutical Medicinal Joint Stock Company's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Pharmedic Pharmaceutical Medicinal Joint Stock Company's PEG Ratio or its related term are showing as below:



HSTC:PMC's PEG Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.655
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Pharmedic Pharmaceutical Medicinal Joint Stock Company PEG Ratio Historical Data

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmedic Pharmaceutical Medicinal Joint Stock Company PEG Ratio Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data
Trend
PEG Ratio

Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data
PEG Ratio

Competitive Comparison of Pharmedic Pharmaceutical Medicinal Joint Stock Company's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmedic Pharmaceutical Medicinal Joint Stock Company's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmedic Pharmaceutical Medicinal Joint Stock Company's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmedic Pharmaceutical Medicinal Joint Stock Company's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Pharmedic Pharmaceutical Medicinal Joint Stock Company's PEG Ratio falls into.



Pharmedic Pharmaceutical Medicinal Joint Stock Company PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Pharmedic Pharmaceutical Medicinal Joint Stock Company  (HSTC:PMC) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Pharmedic Pharmaceutical Medicinal Joint Stock Company PEG Ratio Related Terms

Thank you for viewing the detailed overview of Pharmedic Pharmaceutical Medicinal Joint Stock Company's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Business Description

Traded in Other Exchanges
N/A
Address
367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM
Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, pharmaceuticals, cosmetics, medical supplies, and other products in the health sector.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Headlines

From GuruFocus

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor 08-13-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor 11-16-2009

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk 06-25-2012

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010